NCT05224453

Brief Summary

Sarcopenia is the major health concern and common consequence of COVID-19 in the aging population. Moreover, this clinical condition has not been considered in usual physical rehabilitation practice, and its optimal protein requirement in food is not well defined, which requires a meaningful study in this field. The reports of this trial would deliver the latest evidence and proper guidelines for the prescription of physical exercises and also provide an optimal dietary plan in sarcopenia patients with COVID infection. Objective: To find and compare the clinical and psychological effects of integrated physical training with a high protein diet versus a low-protein diet in community-dwelling COVID-19 asymptomatic older adults with Sarcopenia symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 20, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 4, 2022

Completed
13 days until next milestone

Results Posted

Study results publicly available

February 17, 2022

Completed
Last Updated

February 17, 2022

Status Verified

February 1, 2022

Enrollment Period

1.8 years

First QC Date

January 20, 2022

Results QC Date

February 6, 2022

Last Update Submit

February 16, 2022

Conditions

Keywords

COVID-19Sarcopeniaphysical trainingmuscle strengthmuscle massQuality of lifeprotein diet

Outcome Measures

Primary Outcomes (1)

  • Changes in Hand Grip Strength

    The test is easy to perform and a less expensive one. It measures the strength of upper extremity by using a device handheld dynamometer. The participant was instructed to press the hand piece of the dynamometer to the maximum of his ability and the values shown on the display were recorded. Three values were noted for each participant and the mean value was considered for interpretation and it is a reliable and valid tool to measure the strength of upper extremity.

    At baseline and at 6 months

Secondary Outcomes (3)

  • Change in Muscle Cross Sectional Area

    At baseline and at 6 months

  • Changes in Kinesiophobia

    At baseline and at 6 months

  • Changes in Quality of Life

    At baseline and at 6 months

Study Arms (2)

Physical training and high protein diet

OTHER

Subjects in this group underwent integrated physical training for 8 weeks. In addition to the integrated physical training exercises, group A received a high protein diet in the range of 1.1 - 1.3 g/kg protein/ ideal body weight/day (\>1 g/kg aBW/d).

Other: Physical training and high protein diet

Physical training and low protein diet

OTHER

Subjects in this group underwent integrated physical training for 8 weeks. In addition to the integrated physical training exercises, group B received a low protein diet in the range of 0.7 - 0.9 g/kg protein/ ideal body weight/day (\<1 g/kg aBW/d)

Other: Physical training and low protein diet

Interventions

In addition to the integrated physical training exercises, group A received a high protein diet in the range of 1.1 - 1.3 g/kg protein/ ideal body weight/day (\>1 g/kg aBW/d)

Physical training and high protein diet

In addition to the integrated physical training exercises, group B received low protein diet in the range of 0.7 - 0.9 g/kg protein/ ideal body weight/day (\<1 g/kg aBW/d)

Physical training and low protein diet

Eligibility Criteria

Age60 Years - 80 Years
Sexmale(Gender-based eligibility)
Gender Eligibility Detailspatients with 60 - 80 years of age
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sarcopenia was diagnosed according to the guidelines given by the Asian working group for Sarcopenia (AWGS).
  • Appendicular skeletal muscle mass index (ASMI\< 7.0 kg/m2) Patients with less muscle mass, Low handgrip strength (\< 24 kg) Decrease walking speed (\< 0.7 m/sec)

You may not qualify if:

  • Subjects with a history of physical workout, Taking medicines Recent surgeries Joint problems in the leg Heart and lung problems Neurological issues Other systemic diseases Contraindications for physical training

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Gopal Nambi

Al Kharj, Riyadh Region, 11942, Saudi Arabia

Location

MeSH Terms

Conditions

SarcopeniaCOVID-19

Interventions

Diet, High-ProteinDiet, Protein-Restricted

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Results Point of Contact

Title
Dr. Gopal Nambi
Organization
Prince Sattam bin Abdulaziz University

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Single-blinded, randomized, experimental study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 20, 2022

First Posted

February 4, 2022

Study Start

March 1, 2020

Primary Completion

November 30, 2021

Study Completion

November 30, 2021

Last Updated

February 17, 2022

Results First Posted

February 17, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will share

All the data can be obtained by contacting the principal investigator.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Within one week.
Access Criteria
IPD can be obtained by contacting principal investigator

Locations